ОбзорГрафикНовостиTraderScreen

BVT Bonus Zert GILD 31.12.2024/  DE000VC15G16  /

Frankfurt Zert./VONT
08.11.2024  19:46:13 Изменение+0.660 Бид21:59:49 Предложение21:59:49 Базовый актив Цена исполнения Дата истечения Тип опциона
83.520EUR +0.80% -
Величина цены спроса: -		 -
Величина цены предложения: -		 Gilead Sciences Inc - USD 31.12.2024 Call
GlobeNewswire 27.08 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 27.08 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy
GlobeNewswire 08.08 HOOKIPA Pharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 08.08 Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates
GlobeNewswire 08.08 Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results
GlobeNewswire 06.08 MacroGenics Provides Update on Corporate Progress, Second Quarter 2024 Financial Results
GlobeNewswire 05.08 89bio Reports Second Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire 05.08 89bio Appoints Charles McWherter, Ph.D., to its Board of Directors
GlobeNewswire 01.08 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update
GlobeNewswire 23.07 ACTG Presents Data Analysis at AIDS 2024 Showing Association between Elevated Risk of Cardiovascular...
GlobeNewswire 15.07 Assembly Biosciences Presents New Preclinical Data Highlighting Investigational Helicase-Primase Inh...
GlobeNewswire 08.07 Memo Therapeutics AG appoints Paul Carter as Chairperson
GlobeNewswire 08.07 Memo Therapeutics AG appoints Paul Carter as Chairperson
GlobeNewswire 04.07 Burns McClellan Mourns the Passing of Founder and CEO, Lisa Burns
GlobeNewswire 01.07 HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment o...
GlobeNewswire 01.07 Vera Therapeutics Announces Appointment of Industry Veteran David L. Johnson as Chief Operating Offi...
GlobeNewswire 28.06 Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire 26.06 Neurona Therapeutics Appoints Dr. Nadia Agopyan as Senior Vice President of Regulatory Affairs
GlobeNewswire 26.06 Oruka Therapeutics Announces Key Additions to Leadership Team and Board of Directors
TeleTrader 20.06 US opens mostly higher after labor, housing data
GlobeNewswire 18.06 Assembly Biosciences Doses First Participant in Phase 1b Clinical Trial Evaluating Next-Generation C...
GlobeNewswire 17.06 Assembly Biosciences Announces $12.6 Million in Equity Financings
GlobeNewswire 10.06 Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus He...
GlobeNewswire 22.05 Assembly Biosciences to Present Data at Upcoming International Herpesvirus Workshop and EASL Congres...
GlobeNewswire 14.05 Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results